Valuation: Eckert & Ziegler SE

Market Cap 83Cr 92Cr 76Cr 69Cr 129.15Cr 8.8TCr 131.23Cr 910.53Cr 363.25Cr 4.6TCr 346.61Cr 339.24Cr 15TCr P/E 2026 *
16.2x
P/E 2027 * 15.3x
Enterprise Value 71Cr 79Cr 66Cr 59Cr 111.07Cr 7.56TCr 112.87Cr 783.12Cr 312.42Cr 3.96TCr 298.11Cr 291.76Cr 13TCr EV / Sales 2026 *
2.24x
EV / Sales 2027 * 2.06x
Free-Float
67.36%
Yield 2026 *
1.59%
Yield 2027 * 1.63%
1 day+1.44%
1 week+2.22%
Current month+4.87%
1 month+4.87%
3 months-3.54%
6 months-12.45%
Current year-12.45%
1 week 12.52
Extreme 12.52
13.55
1 month 11.91
Extreme 11.91
13.55
Current year 11.91
Extreme 11.91
16.84
1 year 11.91
Extreme 11.91
17.47
3 years 10.91
Extreme 10.913333
23.25
5 years 9.64
Extreme 9.639999
46.8
10 years 1.74
Extreme 1.740416
47.13
Manager TitleAgeSince
Chief Executive Officer 59 07/06/2023
Chief Tech/Sci/R&D Officer - 01/01/2025
Chief Operating Officer 59 01/01/2025
Director TitleAgeSince
Chairman 57 07/06/2023
Director/Board Member 66 01/01/2014
Director/Board Member 58 01/01/2017
Date Insider Type Main position Quantity % Market Cap. Importance
26/03/24 Sell

Founder

6,720 0.0317%
26/03/24 Buy

Founder

6,720 0.0317%
30/08/23 Sell

Founder

48,000 0.2267%
Change 5-day change 1-year change 3-year change Capi.($)
+1.40%+2.22%-21.41%+10.41% 92Cr
+0.71%+4.82%+27.02%+64.39% 26TCr
+1.24%+3.15%+10.73%+26.13% 17TCr
+1.03%+1.11%-16.52%+73.28% 16TCr
+0.61%-7.22%-57.44%-13.79% 6.19TCr
+2.90%+4.83%+14.21%+53.04% 5.44TCr
+0.52%+2.84%-11.64%-5.94% 5.33TCr
-0.18%+4.18%+26.50%+76.27% 5.11TCr
-2.35%-3.79%+8.26%+63.75% 5.02TCr
+0.67%+5.37%+39.77%+96.14% 4.72TCr
Average +0.54%+1.46%+1.95%+44.37% 9.04TCr
Weighted average by Cap. +0.69%+2.43%+7.23%+50.91%

Financials

2026 *2027 *
Net sales 32Cr 36Cr 29Cr 27Cr 50Cr 3.38TCr 50Cr 349.99Cr 139.63Cr 1.77TCr 133.23Cr 130.4Cr 5.6TCr 34Cr 38Cr 32Cr 29Cr 53Cr 3.63TCr 54Cr 376.22Cr 150.09Cr 1.9TCr 143.22Cr 140.17Cr 6.02TCr
Net income 5.17Cr 5.77Cr 4.77Cr 4.31Cr 8.07Cr 549.44Cr 8.2Cr 57Cr 23Cr 287.55Cr 22Cr 21Cr 910.75Cr 5.31Cr 5.93Cr 4.9Cr 4.43Cr 8.29Cr 564.38Cr 8.42Cr 58Cr 23Cr 295.37Cr 22Cr 22Cr 935.51Cr
Net Debt -12Cr -13Cr -11Cr -9.66Cr -18Cr -1.23TCr -18Cr -127.42Cr -51Cr -644.12Cr -49Cr -47Cr -2.04TCr -12Cr -14Cr -11Cr -10Cr -19Cr -1.3TCr -19Cr -134.83Cr -54Cr -681.61Cr -51Cr -50Cr -2.16TCr
Projected Income Statement - Annual - Eckert & Ziegler SE
Logo Eckert & Ziegler SE
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Employees
1,105
Date Price Change Volume
30/26/30 €13.36 +1.06% 41,132
29/26/29 €13.22 -0.60% 81,429
28/26/28 €13.30 +2.39% 1,31,994
27/26/27 €12.99 +0.85% 95,394
26/26/26 €12.88 -1.45% 1,09,530
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Eckert & Ziegler SE
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
13.22EUR
Average target price
21.60EUR
Spread / Average Target
+63.39%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Eckert & Ziegler SE